|
Market Closed -
Nasdaq Stockholm
17:00:00 23/10/2026 BST
|
5-day change | 1st Jan Change | ||
| 1.928 SEK | -2.72% |
|
-4.55% | -2.13% |
| 10-20 | Irlab research behind linepemat published in journal | FW |
| 10-20 | IRLAB Therapeutics AB Announces Publication Of Preclinical Research Underpinning Linepemat In Peer-Reviewed Journal | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -2.72% | -4.55% | +5.47% | +51.81% | -2.13% | -21.78% | -71.98% | -95.58% | - | 28.88M | |
| -2.54% | +1.31% | +7.75% | +6.47% | +18.50% | +54.27% | +114.96% | +422.45% | +1,541.69% | 1,135B | |
| -1.42% | +3.23% | -2.54% | +0.16% | +27.48% | +38.56% | +74.44% | +61.13% | +132.21% | 636B | |
| +0.16% | +0.08% | +7.74% | +10.13% | +25.01% | +25.29% | +95.23% | +161.72% | +367.34% | 505B | |
| -0.31% | +3.09% | +7.57% | +10.08% | +19.10% | +44.14% | +64.80% | +9.87% | +69.44% | 378B | |
| -1.34% | -0.47% | -1.83% | +10.83% | +38.01% | +66.04% | +41.00% | +79.01% | +139.13% | 358B | |
| -0.68% | +2.65% | +7.60% | +0.87% | +16.79% | +22.98% | +50.39% | +65.08% | +71.58% | 295B | |
| -1.20% | +3.04% | +3.42% | +1.22% | -7.01% | +2.33% | +22.86% | +42.55% | +164.36% | 266B | |
| -1.79% | +1.57% | +8.18% | +16.81% | +34.20% | +50.56% | +59.08% | +109.93% | +176.68% | 237B | |
| -0.73% | -0.10% | +4.24% | +20.67% | +27.13% | +29.02% | +99.67% | +132.06% | +110.44% | 193B | |
| -1.74% | +0.21% | +2.83% | -18.86% | -20.02% | -23.95% | -61.85% | -23.19% | +84.44% | 172B | |
| -1.28% | +1.52% | +5.70% | +22.37% | +20.60% | +21.28% | -1.31% | -30.42% | -6.54% | 171B | |
| -2.10% | +4.84% | +0.30% | +9.76% | +15.57% | +24.33% | +41.84% | +185.49% | +565.48% | 133B | |
| -2.41% | +2.90% | -0.03% | -0.98% | +13.98% | +40.27% | +9.55% | +6.74% | +24.88% | 126B | |
| -1.14% | -0.41% | +15.12% | +19.01% | +22.00% | +24.84% | +121.38% | +378.63% | +524.43% | 117B | |
| -1.04% | +1.69% | +0.91% | -1.33% | +3.81% | +16.91% | +28.84% | +6.64% | -7.67% | 102B | |
| -1.11% | +3.03% | +2.80% | -2.51% | -10.40% | -16.52% | -25.09% | -12.91% | +7.11% | 99.44B | |
| -1.72% | +1.81% | +1.13% | +22.71% | +4.29% | +39.29% | +0.09% | +40.65% | +122.23% | 80.39B | |
| -1.25% | -8.22% | +2.71% | +270.08% | +578.54% | +648.32% | +150.88% | -38.72% | - | 79.89B | |
| +2.74% | +6.96% | +2.18% | -8.37% | -17.57% | -2.02% | +54.47% | +76.91% | +471.01% | 71.3B | |
| Average | -1.18% | +1.57% | +4.06% | +22.05% | +40.39% | +54.21% | +43.46% | +78.90% | +253.24% | 257.77B | |
| Weighted average by Cap. | -1.33% | +2.44% | +4.52% | +10.71% | +27.06% | +44.58% | +67.07% | +151.24% | +476.78% |
- Stock Market
- Stocks
- IRLAB A Stock
- Sector IRLAB Therapeutics AB
Select your edition
All financial news and data tailored to specific country editions
